Related references
Note: Only part of the references are listed.Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice
Toshiya Sato et al.
HUMAN MOLECULAR GENETICS (2009)
The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies
Peter O. Bauer et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Cross-Seeding Fibrillation of Q/N-Rich Proteins Offers New Pathomechanism of Polyglutamine Diseases
Yoshiaki Furukawa et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuroendocrine Disturbances in Huntington's Disease
Nadine Saleh et al.
PLOS ONE (2009)
Increased thirst and drinking in Huntington's disease and the R6/2 mouse
Nigel I. Wood et al.
BRAIN RESEARCH BULLETIN (2008)
Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor
Tomoyuki Yamanaka et al.
EMBO JOURNAL (2008)
Increased metabolism in the R6/2 mouse model of Huntington's disease
Jorien M. M. van der Burg et al.
NEUROBIOLOGY OF DISEASE (2008)
Oxytocin, Vasopressin, and the Neurogenetics of Sociality
Zoe R. Donaldson et al.
SCIENCE (2008)
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn et al.
HUMAN MOLECULAR GENETICS (2007)
The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes
Kazuhiko Tagawa et al.
JOURNAL OF NEUROSCIENCE (2007)
Hypothalamic-endocrine aspects in Huntington's disease
Asa Petersen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Sodium channel β4 subunit:: down-regulation and possible involvement in neuritic degeneration in Huntington's disease transgenic mice
Fumitaka Oyama et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective
Zhihua Qiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lgl mediates apical domain disassembly by suppressing the PAR-3-aPKC-PAR-6 complex to orient apical membrane polarity
Tomoyuki Yamanaka et al.
JOURNAL OF CELL SCIENCE (2006)
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
M Björkqvist et al.
HUMAN MOLECULAR GENETICS (2006)
In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets
WG Zhai et al.
CELL (2005)
The transcriptional landscape of the mammalian genome
P Carninci et al.
SCIENCE (2005)
Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates
S Kotliarova et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Orexin loss in Huntington's disease
A Petersen et al.
HUMAN MOLECULAR GENETICS (2005)
Huntingtin-protein interactions and the pathogenesis of Huntington's disease|
SH Li et al.
TRENDS IN GENETICS (2004)
CRE-mediated transcription is increased in Huntington's disease transgenic mice
K Obrietan et al.
JOURNAL OF NEUROSCIENCE (2004)
Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates
H Doi et al.
FEBS LETTERS (2004)
Cellular toxicity of polyglutamine expansion proteins: Mechanism of transcription factor deactivation
G Schaffar et al.
MOLECULAR CELL (2004)
Huntingtin and the molecular pathogenesis of Huntington's disease - Fourth in molecular medicine review series
C Landles et al.
EMBO REPORTS (2004)
Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin - A potential mechanism for loss of huntingtin function in Huntington's disease
A Busch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The hunt for huntingtin function: interaction partners tell many different stories
P Harjes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Transcriptional abnormalities in Huntington disease
KL Sugars et al.
TRENDS IN GENETICS (2003)
Insoluble TATA-binding protein accumulation in Huntington's disease cortex
WMC van Roon-Mom et al.
MOLECULAR BRAIN RESEARCH (2002)
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2002)
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease
EYW Chan et al.
HUMAN MOLECULAR GENETICS (2002)
Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons
Y Sugitani et al.
GENES & DEVELOPMENT (2002)
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
AW Dunah et al.
SCIENCE (2002)
Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice
ZX Yu et al.
HUMAN MOLECULAR GENETICS (2002)
Transcriptional regulation of cortical neuron migration by POU domain factors
RJ McEvilly et al.
SCIENCE (2002)
Interaction of Huntington disease protein with transcriptional activator Sp1
SH Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (Arnt2) gene reveals partial redundancy with Arnt
B Keith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression
ST Suhr et al.
JOURNAL OF CELL BIOLOGY (2001)
Defective development of secretory neurones in the hypothalamus of Arnt2-knockout mice
T Hosoya et al.
GENES TO CELLS (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin:: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis
S Holbert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
POU domain factors in the neuroendocrine system: Lessons from developmental biology provide insights into human disease
B Andersen et al.
ENDOCRINE REVIEWS (2001)
Transcriptional dysregulation in Huntington's disease
JHJ Cha
TRENDS IN NEUROSCIENCES (2000)
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
JS Steffan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
ARNT2 acts as the dimerization partner of SIM1 for the development of the hypothalamus
JL Michaud et al.
MECHANISMS OF DEVELOPMENT (2000)
Share Paper
